MorningSignal
Research Platform
2026-05-26 19:37
Prepared 2026-05-05, post-close. Distribution: PM desk.
A heavy Tuesday night print, with ten US-listed AMC names above $2B market cap on the tape and another nine BMO reports from this morning where the transcripts are now in hand. The headline story is AI infrastructure: AMD beat on revenue (+38% YoY) and guided Q2 to $11.2B (+46% YoY), pushing the stock ~14% higher in after-hours; Arista (ANET) raised its full-year revenue outlook to $11.25B with AI-network revenue now targeted at $3.25B; and Lumentum (LITE) delivered Q3 revenue of $808M (+90% YoY) with Q4 guided as high as $1.01B. Outside AI, the day's most notable disappointments were not in the AMC window but in the BMO catch-ups: Shopify (-12%) and PayPal (-10%) both got punished for soft second-quarter guides despite beating Q1, and Duolingo (reported Monday AMC, traded May 5) sold off ~14% on weak forward bookings — a clear theme of "Q1 was the easy print; Q2 guidance is what matters."
A. Headline Numbers. Revenue of $10.3B beat $9.85B consensus by ~4.5% and grew 38% YoY. Non-GAAP EPS of $1.37 beat the $1.27 consensus by ~7.9% and grew 43% YoY. Quality of the beat is high: data center revenue of $5.8B (+57% YoY, vs $3.67B prior-year) was the dominant contributor, with both EPYC server CPUs and Instinct GPUs cited as drivers. No flagged one-time items.
B. Guidance Assessment. Q2 revenue guided to ~$11.2B ±$300M, implying ~46% YoY growth and a sequential acceleration vs Q1's 38% — a clean raise vs the Street, which had been modeling closer to $10.5B. Non-GAAP gross margin guided to ~56%, which is consistent with mix shift toward higher-margin data center silicon. Underlying assumptions: continued hyperscaler demand for MI350-class accelerators and EPYC ramp. Tone is confident, not aggressive.
C. Growth Trajectory. Revenue acceleration from 38% (Q1) to 46% (Q2 guide) is a clear re-acceleration. Data center compounding 57% YoY against a $3.67B prior-year base means the segment alone is generating roughly $2.1B of incremental revenue annually. Margin trajectory positive — gross margin expansion to 56% from current levels.
D. Transcript Tone Analysis. Su's framing — that data center has become the "primary driver of our revenue and earnings growth" — represents a meaningful escalation from Q4's "engine of growth" language. Su also said the company has "strong and increasing confidence" in reaching tens of billions of dollars in data center AI revenue next year and exceeding the >80% long-term growth target. This is the most definitive language she has used on the AI ramp.
E. Key Q&A Moments. Analysts pushed on supply visibility into MI350 and the Mi450 transition timing. Responses indicated supply is "ramping" to meet demand rather than supply-constrained — a contrast to Arista's tone. No declined questions per available transcript snippets.
F. Stock Performance Assessment. AH move of approximately +4-14% (early reports said +4% in the print, escalated to ~14% as the conference call progressed and the Q2 guide details landed). Move is justified by the magnitude of the guide raise; market is correctly pricing the re-acceleration but may still under-price the long-term margin story.
G. PM Brief. Buy-the-rip / add on any pullback. Conviction: High. Key risk: hyperscaler capex digestion if Q3/Q4 sees any pause, plus geopolitical export controls on advanced GPUs. Catalyst timeline: MI450 ramp commentary at next earnings, plus any Meta/Microsoft/AWS capex guide updates. One-liner for PM: AMD just put a $44.8B-run-rate-implied data center business on the tape with a 46% Q2 acceleration — the AI-pick-and-shovel narrative re-tightens.
A. Headline Numbers. Revenue $2.709B vs $2.62B consensus (~3.4% beat); +35.1% YoY and +8.9% sequentially. Non-GAAP gross margin 62.4% (within 62-63% guided range, down ~100bps QoQ). Cash flow from operations of $1.69B is the standout — high-quality earnings.
B. Guidance Assessment. Q2 revenue guided to ~$2.8B with gross margin 62-63%, operating margin 46-47%, EPS ~$0.88. Full-year 2026 raised to 25% growth (~$11.25B), targeting $3.25B in AI-center revenue with campus revenue maintained at $1.25B. The full-year raise is the bullish signal — Arista has historically guided conservatively, so an in-cycle FY raise is unusual.
C. Growth Trajectory. Revenue growth holding above 30% on a much larger base. AI-network sub-segment is now ~29% of FY26 revenue — material and growing. Margin compression QoQ (63.4% → 62.4%) reflects mix shift to AI products which carry slightly lower margins, but operating leverage offsets.
D. Transcript Tone Analysis. CEO Jayshree Ullal's quote — "Our demand is actually the best I have ever seen in my Arista tenure" — is the most superlative framing she has used. The pairing with "constrained for the next couple of years" on supply is significant: it sets up a multi-year backlog story. The disclosure that AI product acceptance cycles now run "more like six to even eight quarters" is a deferred-revenue tailwind that will spool into 2027.
E. Key Q&A Moments. Analysts pushed on hyperscaler concentration risk and the 800G/1.6T transition cadence. Responses emphasized broadening customer base across AI accelerator types (Nvidia, AMD, custom silicon).
F. Stock Performance Assessment. ANET was up sharply intraday and held into the close. The +25% FY raise relative to prior guide validates the stock's YTD rally.
G. PM Brief. Buy/Add. Conviction: High. Key risk: a hyperscaler capex pause; secondary risk is supply-chain disruption. Catalyst: 800G/1.6T product cycle commentary in late-2026. One-liner: Arista is now the second-clearest AI-pick-and-shovel after AMD, with the added benefit of a multi-year deferred revenue tailwind.
A. Headline Numbers. GAAP net income of $3.2B / $3.13 diluted EPS, but adjusted EPS from continuing ops was $1.06 — the GAAP figure is inflated by the OxyChem divestiture gain, partially offset by derivative losses and early debt redemption premiums. Adjusted EPS vs Street consensus (~$0.58 estimate noted) appears to be a beat, but the noisy GAAP number is the wrong comp.
B. Guidance Assessment. No formal guidance refresh in the release; the focus is on deleveraging — $7.1B of principal debt repaid through May 5, taking principal debt to $13.3B. This is the strategic signal: post-CrownRock and OxyChem sale, OXY is unwinding leverage, not pursuing growth.
C. Growth Trajectory. Oil & gas pre-tax income up to $1.0B on higher realized crude. Midstream/marketing posted -$87M pre-tax loss but adjusted result beat guidance.
D. Transcript Tone. Capital discipline tone consistent with prior quarters. Emphasis on free cash flow and debt reduction, not production growth.
E. Key Q&A. Analyst focus on remaining asset divestitures and the path to investment-grade credit metrics.
F. Stock Performance. Modest AH move; the headline GAAP number caused some confusion but adjusted came in line/slightly ahead.
G. PM Brief. Hold. Conviction: Medium. Thesis is "deleveraging value-unlock" rather than commodity beta. Key risk: a sustained oil price drop below $65 WTI would impair FCF generation. Catalyst: next divestiture or any tender for the 2027/2028 maturity stack. One-liner: OXY is a balance-sheet-recovery story now — own it for the deleveraging, not the production growth.
A. Headline Numbers. Revenue $8.5B vs $8.49B consensus (in-line); +8% YoY. EPS of -$0.15 missed the -$0.03 consensus by ~$0.12 — a substantial miss. Net income swung to a $266M loss vs $107M profit in Q1 2025. Adjusted EBITDA of $29M / 0.3% margin, down 449 bps YoY. Gross profit $2.3B, -1% YoY, with gross margin compressed 228 bps to 27.0%.
B. Guidance Assessment. Developing Offerings (DO) segment loss guided to $950M-$1B for full-year 2026 (roughly in line with internal expectations but elevated; Q1 DO loss was $329M). No formal full-year EPS guide.
C. Growth Trajectory. Revenue growth has slowed from double-digit territory to 8% — a clear deceleration. Bottom-line trajectory is materially worse than prior-year comp due to DO segment investments (Taiwan, Japan).
D. Transcript Tone. Management emphasized that Q4 2025 data incident recovery is "progressing faster than expected" and framed DO losses as on-plan. Tone was patient, defensive on profitability questions.
E. Key Q&A. Analysts pushed hard on the path to Korean core profitability and DO breakeven timing. Responses emphasized "operational efficiency" but were light on specific milestones — a yellow flag.
F. Stock Performance. Stock rose 2.47% in AH to $20.40, suggesting investors prioritized the Q1 revenue beat and recovery narrative over near-term profitability. The market is pricing in DO investments as a transient issue rather than a structural margin problem.
G. PM Brief. Hold. Conviction: Low. The thesis hinges on whether Korea-core profitability can fund DO losses without diluting equity. Key risk: a Korea consumer slowdown that hits the cash cow. Catalyst: any sign of DO segment revenue inflection in Q2/Q3. One-liner: Coupang is asking the market to underwrite a multi-year DO investment cycle — only own this if you believe in the Korea moat.
A. Headline Numbers. Net loss of $12.54B / -$38.25 diluted EPS, vs Street -$18.98 — a "miss" of -101% on EPS. Revenue (software business) of $124.3M vs $125.07M consensus, immaterial. The loss is almost entirely driven by mark-to-market on Bitcoin holdings under the new fair-value accounting standard, NOT operational deterioration.
B. Guidance Assessment. No traditional revenue guidance. Bitcoin holdings now 818,334 BTC, +22% since January. Average cost basis ~$75,537 vs May 1 price ~$78,374. Implied unrealized gain across the position remains positive but smaller than at Q1-end peak prices.
C. Growth Trajectory. Bitcoin treasury continues to compound; software business is roughly stagnant.
D. Transcript Tone. Saylor's tone characteristically bullish on Bitcoin accumulation. Pause on weekly purchases ahead of earnings was framed as routine, not strategic.
E. Key Q&A. Focus on how the new accounting standard will distort GAAP earnings going forward; analysts asked about ATM issuance pacing.
F. Stock Performance. Stock rose despite the GAAP miss — the market correctly identified the loss as accounting noise rather than fundamental deterioration. This is a healthy reaction.
G. PM Brief. Hold (or trade as a Bitcoin proxy). Conviction: Low on absolute call, High that the stock will continue trading as a leveraged BTC ETF. Key risk: BTC drawdown >25% would compress the equity premium meaningfully. Catalyst: any new STRK/STRF preferred issuance or a BTC breakout. One-liner: MSTR is a balance-sheet vehicle for Bitcoin — fundamental analysis is irrelevant; trade the BTC chart.
A. Headline Numbers. Revenue $3.79B (+12.1% YoY), beating consensus of $3.57B by ~6.1%. GAAP EPS of -$1.85 (vs -$0.32 prior-year) and Adjusted EBITDA -$168.4M vs $337.5M consensus — but both metrics impacted by a $450M legal accrual. Ex-the-charge, Adjusted EBITDA would be roughly $282M, still a miss vs consensus but in a defensible range.
B. Guidance Assessment. No formal numeric guide refresh, but management reaffirmed the multi-year venue expansion thesis. Securitization of >€600M in venue assets unlocks additional leverage capacity.
C. Growth Trajectory. Concerts revenue $2.8B (+12% YoY); 85% of 2026 large-venue shows booked through end-April; tickets sold for 2026 concerts +11% to over 107M. Sponsorship AOI +21% to $165M. Underlying business is healthy; the margin compression is non-recurring.
D. Transcript Tone. Management framing on the legal accrual was matter-of-fact rather than apologetic; tone on the underlying business remains strong.
E. Key Q&A. The DOJ antitrust overhang is the elephant in the room. Analyst pushback on the sufficiency of the $450M accrual — management was guarded.
F. Stock Performance. Mixed reaction — the headline EPS miss is bad optics, but the revenue beat and reaffirmed booking trajectory provide support.
G. PM Brief. Hold. Conviction: Medium. The legal overhang is the wildcard — any structural remedy (forced divestiture of Ticketmaster) would be a multi-multiple compression event. Key risk: DOJ trial outcome. Catalyst: legal proceedings late-2026/2027. One-liner: LYV's underlying business is firing on all cylinders; the legal overhang means we don't get paid to own that until a settlement crystallizes.
A. Headline Numbers. Q3 FY26 revenue of $808.4M vs prior-quarter $665.5M and prior-year $425.2M — revenue nearly doubled YoY (+90.1%). Non-GAAP gross margin 47.9% (vs typical 35-40% historical range); non-GAAP operating margin 32.2%. Non-GAAP diluted EPS of $2.37; GAAP $1.50. Components revenue $533.3M, Systems $275.1M.
B. Guidance Assessment. Q4 FY26 revenue guided to $960M-$1.01B — a ~$200M sequential step-up — with non-GAAP operating margin of 35-36% and EPS of $2.85-$3.05. This is a clean raise vs Street and implies continued AI-optical demand acceleration.
C. Growth Trajectory. Revenue acceleration from $425M (Q3 FY25) → $665M (Q2 FY26) → $808M (Q3 FY26) → ~$985M (Q4 FY26 guide-mid) — that's a >100% trailing-twelve-months growth rate now. Operating margin expanding 200+ bps QoQ.
D. Transcript Tone. Management language confident on the AI optical ramp; Cloud & Networking customer demand cited as the dominant driver. Capital intensity rising but framed as accretive.
E. Key Q&A. Capacity ramp and customer concentration. Stifel and Loop Capital both raised PTs (to $1,100 and $1,400 respectively) post-call — a strong sell-side signal.
F. Stock Performance. AH +1.9% — modest given the magnitude of the beat and guide raise. The stock is up ~1,444% from the trough; some of the move was already priced. AH reaction is a buying opportunity if the fundamental signal is correct.
G. PM Brief. Buy. Conviction: High. Key risk: AI optical demand pause if hyperscaler capex moderates; secondary risk is competitive entry from Coherent. Catalyst: 800G/1.6T transition commentary on next call. One-liner: Lumentum just printed the cleanest "AI optical pure-play" datapoint of the cycle and the AH reaction underprices it.
A. Headline Numbers. Revenue $1,045.4M (+21.2% YoY); GAAP EPS -$0.36 vs -$0.32 consensus (a ~$0.04 miss). Net loss narrowed to $117.1M from $202.1M YoY. Adjusted EBITDA swung positive to $38.3M from -$57.7M — best Q1 EBITDA since 2019. Attendance 47.6M patrons (+13.6%).
B. Guidance Assessment. No formal multi-quarter EPS guide. Management commentary is constructive on the 2026 box-office slate.
C. Growth Trajectory. Top-line recovery is real — 21% revenue growth on industry box-office rebound. EBITDA inflection from negative to positive is the key fundamental signal. Margin recovery still partial.
D. Transcript Tone. Improved, but still defensive given the historical balance-sheet narrative.
E. Key Q&A. Capital structure — analysts continue to push on debt maturity profile and dilution risk.
F. Stock Performance. AMC remains an idiosyncratic retail-driven name; fundamental reaction is muted relative to flow-driven moves.
G. PM Brief. Hold (or avoid). Conviction: Low. Improving fundamentals, but balance-sheet and dilution risk dominate the narrative. Key risk: equity issuance at depressed prices. Catalyst: 2026 summer box-office slate. One-liner: The operating story is finally inflecting, but until the balance sheet is fixed, it doesn't translate into equity returns.
A. Headline Numbers. Adjusted operating earnings of C$2.30B / C$1.93 EPS, up from C$1.629B / C$1.31 prior-year. Net earnings C$2.1B. Adjusted funds from ops C$4.03B; free funds flow C$2.91B. Records on upstream production (875,200 bbls/d), refinery throughput (497,800 bbls/d), and refined product sales (680,900 bbls/d).
B. Guidance Assessment. 2026 share repurchase target raised to ~C$4B for the year (from prior). Dividend C$0.60/share.
C. Growth Trajectory. Operational records across upstream and downstream. Margin trajectory positive on higher upstream realizations and downstream margins.
D. Transcript Tone. Operationally confident; capital return prioritized. Webcast scheduled for May 6 morning — full transcript pending for AM brief tomorrow.
E. Key Q&A. Pending May 6 call — to be assessed in tomorrow's brief.
F. Stock Performance. Print released after-close NYSE / pre-call; stock reaction modest.
G. PM Brief. Hold/Buy on weakness. Conviction: Medium. Solid operator; upside to consensus on the buyback acceleration. Key risk: WCS-WTI differential blowout. Catalyst: May 6 call commentary on 2027 capex. One-liner: A textbook integrated-oil execution print — reward is in the buyback math, not the headline.
A. Headline Numbers. Q1 net earnings $120M, free cash flow $816M, production 833,000 BoE/d. Coterra all-stock merger advancing with $1B synergy target. Consensus had been ~$1.00 EPS / $4.14B revenue.
B. Guidance Assessment. Coterra synergies provide the forward narrative; standalone guide steady.
C. Growth Trajectory. Production growth deferred pending merger close.
D. Transcript Tone. Strategic / merger-focused; less production-quarter color than usual.
E. Key Q&A. Pending May 6 call (10am CDT scheduled).
F. Stock Performance. Modest; merger arb dynamics are the dominant driver.
G. PM Brief. Hold. Conviction: Medium. The merger is the story; standalone results are noise until close. Key risk: regulatory or shareholder vote risk on the Coterra deal. Catalyst: deal close timing. One-liner: DVN is a merger-arb stock now — own it for the synergy unlock, not the Q1 print.
The morning brief flagged transcripts pending for several names. Below is the full post-mortem now that calls have concluded and full-day stock action is in.
Q1 EPS $1.34 vs $1.27 (~5.5% beat); revenue $8.4B vs $8.05B (~4.4% beat); TPV $464B (+11% spot, +8% cc). The Q1 headline read clean.
The break: Q2 adjusted EPS guided to a -9% YoY decline — the contracting EPS curve is incompatible with growth-multiple valuation. Stock fell ~10% intraday to ~$45.50, holding into the close. The market's reaction is rational given fintech valuation sensitivity to forward EPS. CEO commentary on the AI-driven cost-out plan ($1.5B reinvestment) was framed as multi-year transformation — the market wants in-quarter results, not 2027 promises. Operating expense growth and Europe softness were the specific Q&A pressure points.
Validation of morning read: The morning brief flagged "transcript pending" with neutral fundamental read; the full-day -10% confirms the Q2 guide was the dominant signal. The sell-off makes sense — initial market reaction was correct.
PM call: Hold/wait. Conviction: Medium-Low on near-term direction, Medium on long-term thesis post-reset. Re-engage on a Q2/Q3 inflection signal (growth re-acceleration above guide).
Revenue $14.45B vs $13.92B (~3.8% beat); adjusted EPS $0.75 vs $0.72 (~4.1% beat). Total revenue +5% YoY (+2% operational; +7% ex-COVID products). Launch & acquired products $3.1B (+22% operational).
Why no upside: Pfizer reaffirmed but did not raise 2026 guidance ($2.80-$3.00 EPS / $59.5-$62.5B revenue). With consensus already near the mid-point, a non-raise on a beat tells the buyside the back half is being held conservatively — or that there is no operating leverage. COVID franchise continues to decay (vaccine -59% YoY to $232M; Paxlovid -62% to $186M).
Stock performance: Drifted -0.6% to $26.15 by mid-afternoon; closed roughly flat. Muted reaction is appropriate — beat without raise is a wash.
Validation of morning read: Morning brief should have flagged the non-raise as the bear signal. Full-day flat-to-down confirms the soft underlying read.
PM call: Hold. Conviction: Low. The defensive yield play remains intact, but lack of catalyst path is a concern. Re-engage if Q2 raises FY guide, or on a major late-stage data readout.
Q1 Adjusted EBITDA $4.9B (vs $4.1B prior-year); DCF as adjusted $2.7B (vs ~$2.3B prior-year). Multiple operational records: NGL/refined products terminal volumes +19%, NGL exports +19%, NGL fractionation +11%, crude oil transport +8%. Organic growth capex $1.5B in Q1.
The raise: 2026 Adjusted EBITDA guide raised to $18.2-$18.6B from $17.45-$17.85B — a $750M midpoint raise, ~4.3%. Organic growth capex guide raised to $5.5-$5.9B from $5.0-$5.5B as new growth projects are added.
Stock performance: Constructive intraday action; the raise validates the thesis.
Validation of morning read: The combination of record operational metrics + raised guidance is unambiguously bullish. The morning read should be confirmed.
PM call: Buy. Conviction: High. Yield + EBITDA growth re-acceleration is a rare combination. Key risk: distribution coverage if growth capex pulls forward. One-liner: ET's Q1 was the best hard-asset midstream print of the cycle — own it.
Q1 revenue $3.17B (+34% YoY) vs $3.09B consensus (~2.6% beat). GMV $101B (+35%). Merchant solutions strongest segment growth in 4+ years. The Q1 print was clean.
The break: Q2 revenue guided to "high-twenties percentage" growth — a deceleration from Q1's 34%. Gross profit guided to "mid-twenties" growth, suggesting bottom-line will come in below sell-side models. The market does not pay 12-15x sales for a decelerating 25-30% grower.
Stock performance: Down 12.6% by mid-afternoon to ~$108. This is the largest single-day fundamental sell-off in the consumer tech complex today.
Validation of morning read: A clean decelerating-growth tape read — initial morning interpretation should have caught this. Full-day -12% confirms the Q2 guide as the dominant signal.
PM call: Sell-the-rip / wait for reset. Conviction: Medium. The platform is quality, but at current multiples a single quarter of decel = -12%. Need to see growth re-acceleration before re-engaging — likely a 2-3 quarter wait.
Underlying EPS $0.97 (+20.8% YoY); revenue +5.8% organically to $15.27B. Volumes +0.8%. Normalized EBITDA +5.3%. Premium brands (Budweiser, Corona, Stella) driving the mix shift; no-alcohol +27%, Beyond Beer +37%, BEES marketplace GMV +55%.
Stock performance: +10.24% to $81.48 — the day's biggest large-cap consumer-staples move. Premium beer and emerging-market growth combination is finally being rewarded.
Validation of morning read: Strong morning read; full-day +10% validates.
PM call: Buy/Hold. Conviction: Medium-High. The premiumization narrative + emerging-market exposure is well-positioned for a soft-dollar regime. Key risk: weight-loss-drug-driven beer-volume erosion in developed markets. Catalyst: continued mix shift commentary.
Q1 adjusted EPS $1.93 vs $1.888 consensus (~2.2% beat); revenue $9.18B vs $8.52B (~7.7% beat — the headline number on the print). FY26 adjusted EPS guide of $6.55-$6.80 affirmed (vs $6.70 consensus — i.e., consensus is mid-point).
Stock performance: Modestly higher on the day; classic regulated-utility "in-line beat" reaction.
Validation of morning read: The beat without raise is consistent with utility-sector earnings cadence. Full-day muted-positive validates.
PM call: Hold. Conviction: Medium. Defensive yield with regulated growth; data center load growth provides a 2027+ catalyst. Key risk: rate-case unfavorable outcomes. Catalyst: data-center-load disclosure on the call.
Q1 revenue $8.4B (+3% YoY); net income $654M / $4.71 diluted EPS — but reduced by a $199M charge from the low-pressure fuel cell divestiture. Adjusted core operations were stronger than the headline EPS suggests.
The raise: FY26 revenue guide lifted to up 8-11% (from up 3-8% prior); EBITDA margin guide to 17.75-18.50% (from 17.0-18.0%). The magnitude of the FY raise — moving the revenue range up ~5 percentage points at the midpoint — is unusual mid-year and is the dominant signal.
Stock performance: +4.22% in pre-market to $684.47, holding most of the gain through the session. The market correctly looked through the one-time charge.
Validation of morning read: Strong morning interpretation; full-day +4% validates that the guide raise was the dominant signal vs the GAAP EPS miss.
PM call: Buy. Conviction: High. Power Systems segment (data-center back-up power) is the structural tailwind; the FY guide raise crystallizes it. Key risk: Class 8 truck cycle deterioration in 2H26. One-liner: Cummins is the cleanest data-center-power proxy in the industrial complex — the FY guide raise is a multi-quarter signal.
Q2 FY26 sales $2.54B (+18% YoY); net income $536M; adjusted EPS $9.85 vs $9.53 consensus (~3.4% beat); EBITDA As Defined $1.34B. Revenue beat ~3.7% vs consensus.
The raise: FY26 guide raised to revenue $10.30-$10.42B (midpoint ~$10.36B), EBITDA As Defined ~$5.42B, adjusted EPS $38.83-$40.21 (midpoint ~$39.52). Plus closed a $2.2B acquisition and executed $905M of share buybacks during the quarter.
Stock performance: +6.11% in pre-market to $1,219.99, held through the session.
Validation of morning read: Aerospace aftermarket strength + accretive M&A + raised guide is unambiguously bullish. Full-day move validates.
PM call: Buy. Conviction: High. The aerospace aftermarket compounder thesis remains intact. Key risk: any commercial aerospace traffic shock (recession, fuel spike, geopolitical). Catalyst: integration of the $2.2B acquisition.
Q1 EPS $1.79 vs $1.57 (~14% beat) — but adjusted EPS was actually -16% YoY. Revenue $4.68B (-2.4% YoY). Organic revenue -4% (Merchant Solutions -1%, Financial Solutions -6%). Adjusted operating margin 29.7% vs 37.8% prior-year — meaningful margin compression.
The signal: A beat on EPS that is built on cost cuts rather than operating leverage, paired with organic revenue decline and margin compression, is a classic "beat that misses." FY26 guide unchanged at 1-3% organic growth and $8.00-$8.30 EPS.
Stock performance: Sold off intraday despite the EPS beat — investors correctly identified that the EPS line was rescued by cost cuts and that the organic top line is the worry.
Validation of morning read: The organic revenue decline was the bear signal; full-day sell-off confirms the morning read should have been cautious despite the EPS beat.
PM call: Sell/avoid. Conviction: Medium. Investor Day on May 14 is the next catalyst — wait for that before re-engaging. Key risk: continued organic revenue decline. Catalyst: Investor Day reset of guidance/strategy.
1. AI infrastructure remains the dominant tape narrative. AMD, ANET, and LITE all printed clean beats with raised forward guides specifically tied to AI. AMD's data center +57% YoY, ANET's $3.25B AI-network FY26 target, and LITE's 90% YoY revenue growth collectively re-validate the picks-and-shovels thesis. The AH reactions (AMD +14%, LITE +1.9%) suggest the AMD print was more decisively above expectations, while LITE's move underprices the magnitude of its result — possible alpha here.
2. Q2 guidance is the make-or-break variable, not Q1 results. SHOP and PYPL both beat Q1 cleanly and sold off ~10-12% on soft Q2 outlooks. Duolingo (Monday AMC, traded May 5) -14% on similar dynamic. The buyside is no longer paying for trailing-quarter beats; forward decel = sell.
3. Industrial complex bifurcation continues — data center power wins, traditional capex stalls. Cummins raised FY guide by ~5 percentage points specifically on Power Systems strength, while TransDigm raised on aero aftermarket. Capital-equipment names tied to data-center build-out are decoupling from broader industrial cycles.
4. Energy quietly delivered. ET raised EBITDA guide $750M; OXY accelerated deleveraging; Suncor printed records across upstream and downstream. The sector is being underweighted by growth funds while throwing off elevated FCF — a quiet relative-value setup.
5. Beat-without-raise = punished; raise-without-headline-beat = rewarded. Pfizer (beat, no raise = flat); Cummins (EPS miss on charge, but FY raise = +4%); Fiserv (EPS beat but organic decline = sold off). The market is reading guidance more than headlines.
Before the open:
After the close (May 6 AMC):
Watch-list priorities: DIS, UBER, and ARM are the names with highest beta to the broader tape; NVO is the highest-conviction GLP-1 readthrough.
End of brief. Next update: 2026-05-06 AM (BMO reporters) and PM (AMC reporters including ARM, APP, WBD).